"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."

Margaret Mead
TO ARTICLE
METRICS

Review article
peer-reviewed

The Hypervirulent Strain of Clostridium Difficile: NAP1/B1/027 - A Brief Overview


Total Article Reads

Article reads consist of online article views and PDF downloads. Cureus data is delayed by 24 hours and PMC data is delayed by approximately one month.

Total Article Reads Cureus PMC
16,709 Article Views 2,268 12,575
PDF Downloads 946 920
Total Article Reads Cureus PMC
16,709 Article Views 2,268 12,575
PDF Downloads 946 920
Total Article Reads
16,709
Cureus PMC
Article Views 2,268 12,575
PDF Downloads 946 920

Article Reads by Date

Hover your cursor over a specific day or month to see the corresponding online article views and PDF downloads. Cureus data is delayed by 24 hours and PMC data is delayed by approximately one month.

Cureus Article Reads

Loading...

Cumulative Cureus and PMC Article Reads

Loading...

Article Reads by Country

Hover your cursor over a country to see the number of online article views and PDF downloads from Cureus only.
Note: PMC does not share location data and not all Cureus reads are included below as location data is not available for all IP addresses.


Rank Country Views Percentage

Article Reads by U.S. States

Hover your cursor over a state to see the number of online article views and PDF downloads from Cureus only.
Note: PMC does not share location data and not all Cureus reads are included below as location data is not available for all IP addresses.


Rank State Views Percentage

Citations

Citation index reporting varies. Crossref citations are listed below and Google Scholar citations can be seen by clicking the corresponding button.

Google Scholar  
Crossref Citations (16)
  1. Johnstone, M. A., Landgraf, A. D., Si, A., Sucheck, S. J., & Self, W. T. (2022). Evaluation of Derivatives of (+)-Puupehenone against Clostridioides difficile and Other Gram-Positive Bacteria. ACS Omega, 7(37), 33511–33517. https://doi.org/10.1021/acsomega.2c04471 doi:10.1021/acsomega.2c04471.
  2. Zeng, J., Wang, H., Dong, M., & Tian, G.-B. (2022). Clostridioides difficile spore: coat assembly and formation. Emerging Microbes & Infections, 1–28. https://doi.org/10.1080/22221751.2022.2119168 doi:10.1080/22221751.2022.2119168.
  3. Boeriu, A., Roman, A., Fofiu, C., & Dobru, D. (2022). The Current Knowledge on Clostridioides difficile Infection in Patients with Inflammatory Bowel Diseases. Pathogens, 11(7), 819. https://doi.org/10.3390/pathogens11070819 doi:10.3390/pathogens11070819.
  4. Kim, D., Kim, Y.-R., Hwang, H.-J., Ciufolini, M. A., Lee, J., Lee, H., Clovis, S., Jung, S., Oh, S.-H., Son, Y.-J., & Kwak, J.-H. (2022). Nitro-Group-Containing Thiopeptide Derivatives as Promising Agents to Target Clostridioides difficile. Pharmaceuticals, 15(5), 623. https://doi.org/10.3390/ph15050623 doi:10.3390/ph15050623.
  5. Kabała, M., Gofron, Z., Aptekorz, M., Sacha, K., Harmanus, C., Kuijper, E., & Martirosian, G. (2021). Clostridioides difficile Ribotype 027 (RT027) Outbreak Investigation Due to the Emergence of Rifampicin Resistance Using Multilocus Variable-Number Tandem Repeat Analysis (MLVA). Infection and Drug Resistance, Volume 14, 3247–3254. https://doi.org/10.2147/idr.s324745 doi:10.2147/IDR.S324745.
  6. Wongkuna, S., Janvilisri, T., Phanchana, M., Harnvoravongchai, P., Aroonnual, A., Aimjongjun, S., … Chankhamhaengdecha, S. (2021). Temporal Variations in Patterns of Clostridioides difficile Strain Diversity and Antibiotic Resistance in Thailand. Antibiotics, 10(6), 714. doi:10.3390/antibiotics10060714.
  7. Muhammad, A., Madhav, D., Rawish, F., Viveksandeep, T. C., Albert, E., Mollie, J., & Prateek, S. (2019). Surotomycin (A Novel Cyclic Lipopeptide) vs. Vancomycin for the Treatment of Clostridioides difficile Infection: A Systematic Review and Meta-analysis. Current Clinical Pharmacology, 14(3), 166–174. doi:10.2174/1574884714666190328162637.
  8. Oka, D., Yamaya, N., Kuno, T., Asakawa, Y., Shiragiku, T., Chen, L., … Matsumoto, M. (2021). In Vitro and In Vivo Antibacterial Activities of a Novel Quinolone Compound, OPS-2071, against Clostridioides difficile. Antimicrobial Agents and Chemotherapy, 65(4). doi:10.1128/AAC.01170-20.
  9. Dhungel, B. A., & Govind, R. (2020). Spo0A Suppresses sin Locus Expression in Clostridioides difficile. mSphere, 5(6). doi:10.1128/mSphere.00963-20.
  10. Waker, E., Ambrozkiewicz, F., Kulecka, M., Paziewska, A., Skubisz, K., Cybula, P., … Ostrowski, J. (2020). High Prevalence of Genetically Related Clostridium Difficile Strains at a Single Hemato-Oncology Ward Over 10 Years. Frontiers in Microbiology, 11. doi:10.3389/fmicb.2020.01618.
  11. Muhammad, A., Simcha, W., Rawish, F., Sabih, R., Albert, E., & Ali, N. (2020). Cadazolid vs Vancomycin for the Treatment of Clostridioides difficile Infection: Systematic Review with Meta-analysis. Current Clinical Pharmacology, 15(1), 4–10. doi:10.2174/1574884714666190802124301.
  12. Nomura, M., Kuroda, T., Tamura, N., Muranaka, M., & Niwa, H. (2020). Mortality, clinical findings, predisposing factors and treatment of Clostridioides difficile colitis in Japanese thoroughbred racehorses. Veterinary Record, 187(2), e14–e14. doi:10.1136/vr.105605.
  13. Amjad, M. (2020). An Overview of the Molecular Methods in the Diagnosis of Gastrointestinal Infectious Diseases. International Journal of Microbiology, 2020, 1–13. doi:10.1155/2020/8135724.
  14. Usui, Y., Nukui, Y., Koike, R., Tohda, S., & Saito, R. (2020). Draft Genome Sequence of a Clostridioides difficile Sequence Type 97 Strain Belonging to Hypervirulent Clade 2. Microbiology Resource Announcements, 9(14). doi:10.1128/MRA.00245-20.
  15. Negrut, N., Nistor-Cseppento, D. C., Khan, S. A., Pantis, C., Maghiar, T. A., Maghiar, O., … Bungau, S. (2020). Clostridium difficile Infection Epidemiology over a Period of 8 Years—A Single Centre Study. Sustainability, 12(11), 4439. doi:10.3390/su12114439.
  16. Cebrián, R., Macia-Valero, A., Jati, A. P., & Kuipers, O. P. (2019). Design and Expression of Specific Hybrid Lantibiotics Active Against Pathogenic Clostridium spp. Frontiers in Microbiology, 10. doi:10.3389/fmicb.2019.02154.

Article Research Metrics

We’ve partnered with Plum Analytics to track and display research metrics for each article. (All data provided by PlumX Metrics.) Click here to learn more about Plum Analytics.